PMID- 38358185 OWN - NLM STAT- MEDLINE DCOM- 20240221 LR - 20240221 IS - 0974-5130 (Electronic) IS - 0377-4929 (Linking) VI - 67 IP - 1 DP - 2024 Jan-Mar TI - High expression of SHP2 predicts a promising prognosis in colorectal cancer. PG - 29-35 LID - 10.4103/ijpm.ijpm_894_22 [doi] AB - BACKGROUND: Src homology 2 domain-containing phosphatase 2 (SHP2) is hyper-activated in some solid tumors. Previous findings suggest that the expression of SHP2 in colorectal cancer (CRC) may be associated with prognosis. However, validation with large sample data is lacking. Materials and Methods: Tissue microarrays containing 860 CRCs and 197 mucosal tissues adjacent to the tumors were constructed. Immunohistochemistry was used to evaluate the expression of SHP2. Differences between SHP2 expression and clinicopathological parameters were evaluated. Kaplan-Meier survival curves and log-rank tests were used to analyze the relationships between SHP2 expression and the overall survival of patients. A Cox proportional hazard regression model was used for univariate and multivariate analyses of prognostic factors. RESULTS: SHP2 expression in CRCs tissues was significantly higher than those in adjacent mucosal tissues (P < 0.001). SHP2 expression was related to tumor differentiation, depth of invasion, distant metastasis, vascular tumor thrombus, lymph node metastasis, and TNM classification (P < 0.05). The prognosis of the high-expression group of SHP2 was significantly better than that of the low-expression group (P = 0.008). Univariate analysis showed that the expression of SHP2 was a prognostic factor for CRC (P = 0.008). Multivariate analysis demonstrated that SHP2 remained an independent prognostic factor for CRC (P = 0.033). CONCLUSION: The expression of SHP2 was significantly higher in CRC tissues than in adjacent normal tissues. High expression of SHP2 was associated with a promising outcome, suggesting that SHP2 may be a favorable prognostic indicator of CRC. FAU - Liu, Xibo AU - Liu X AD - Department of Pathology, Shaoxing People's Hospital, Shaoxing, China. FAU - Li, Mengyao AU - Li M AD - Department of Pathology, Shaoxing People's Hospital, Shaoxing, China. FAU - Chen, Lirong AU - Chen L AD - Department of Pathology, China National Ministry of Education), The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. FAU - Wen, Fei AU - Wen F AD - Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. FAU - Zheng, Shu AU - Zheng S AD - Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. FAU - Ge, Weiting AU - Ge W AD - Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. LA - eng PT - Journal Article PL - India TA - Indian J Pathol Microbiol JT - Indian journal of pathology & microbiology JID - 7605904 RN - 0 (Biomarkers, Tumor) RN - EC 3.1.3.48 (PTPN11 protein, human) SB - IM MH - Humans MH - *Biomarkers, Tumor/analysis MH - *Colorectal Neoplasms/pathology MH - Lymphatic Metastasis MH - Neoplasm Staging MH - Prognosis OTO - NOTNLM OT - Colorectal neoplasms OT - SHP2 OT - immunohistochemistry OT - prognosis OT - tissue microarrays EDAT- 2024/02/15 12:42 MHDA- 2024/02/16 06:43 CRDT- 2024/02/15 08:47 PHST- 2024/02/16 06:43 [medline] PHST- 2024/02/15 12:42 [pubmed] PHST- 2024/02/15 08:47 [entrez] AID - IndianJPatholMicrobiol_2024_67_1_29_381975 [pii] AID - 10.4103/ijpm.ijpm_894_22 [doi] PST - ppublish SO - Indian J Pathol Microbiol. 2024 Jan-Mar;67(1):29-35. doi: 10.4103/ijpm.ijpm_894_22.